NCT03523039 (CATCH) is a NA clinical trial of CytoSorb® Hemoadsorption in Cardiac Arrest, sponsored by Centre Hospitalier Universitaire Vaudois.

Who is sponsoring NCT03523039?

NCT03523039 is sponsored by Centre Hospitalier Universitaire Vaudois.

What drugs are being tested in NCT03523039?

Interventions in NCT03523039: CytoSorb® Hemoadsorption.

What condition does NCT03523039 study?

NCT03523039 studies Cardiac Arrest.

Is NCT03523039 still recruiting?

NCT03523039 is currently completed. Last updated 14 March 2022.

Last reviewed 2022-03-14 · How we verify

NCT03523039: CATCH

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hemoadsorption With CytoSorb® in Post-Cardiac Arrest Syndrome

Completed NA Last updated 14 March 2022

What this trial tests

NA trial testing CytoSorb® Hemoadsorption in Cardiac Arrest in 21 participants. Completed in 1 March 2022.

Timeline

18 February 2019

Primary endpoint
1 December 2021

1 March 2022

Quick facts

Lead sponsor	Centre Hospitalier Universitaire Vaudois
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	21
Start date	18 February 2019
Primary completion	1 December 2021
Estimated completion	1 March 2022
Sites	1 location across Switzerland

Drugs / interventions tested

CytoSorb® Hemoadsorption

Conditions studied

Cardiac Arrest — all drugs for Cardiac Arrest →

Sponsor

Centre Hospitalier Universitaire Vaudois

Who can join

18 and older, any sex, with Cardiac Arrest. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective single-centre randomized control trial aims at evaluating the safety and efficacy of hemoadsorption with CytoSorb® in 40 patients with Post-Cardiac Arrest Syndrome admitted to the ICU.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Mortality and adverse events of hemoadsorption with CytoSorb® in critically ill patients: A systematic review and meta-analysis of randomized controlled trials.
Heymann M, Schorer R, Putzu A. · · 2022 · cited 32× · PMID 35788557 · DOI 10.1111/aas.14115
Cytokine hemoadsorption with CytoSorb<sup>®</sup> in post-cardiac arrest syndrome, a pilot randomized controlled trial.
Monard C, Bianchi N, Poli E, Altarelli M, et al · · 2023 · cited 18× · PMID 36691082 · DOI 10.1186/s13054-023-04323-x

Verify or expand the search:

Other recruiting trials for Cardiac Arrest

Currently open trials in the same condition.

NCT07239206 — Serious Game for Improving Targeted Temperature Management Knowledge and Situational Awareness in Critical Care Nurses · NA · recruiting
NCT06780722 — Study of the Occurrence of Cardiocirculatory Arrest as a Function of the Level of Hypoxemia During a Maastricht 3 Proced · recruiting
NCT06405581 — The Impact of Frailty on Cardiopulmonary Resuscitation Adverse Outcomes in Patients Requiring Code Blue Activation · recruiting
NCT06511999 — Continuous Jugular Venous Oxygen Saturation (SjO2) Measurement After Cardiac Arrest · recruiting
NCT07113769 — Plasma Biomarkers and Platelet Morphology of Extracorporeal CardioPulmonary Resuscitation · recruiting

Other Centre Hospitalier Universitaire Vaudois trials

Trials by the same sponsor.

NCT07427511 — SwissNeuroRehab - HDHI · NA · recruiting
NCT07263438 — Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a · Phase 2 · recruiting
NCT07139756 — Deciphering the Mechanisms of Central BP Regulation in Patients With PD Associated With Orthostatic Hypotension · not yet recruiting
NCT07109388 — Comparison of Pericapsular Nerve Group (PENG) Block With a Combined Femoral, Sciatic, Lateral Femoral Cutaneous Nerve Bl · NA · not yet recruiting
NCT07268378 — Supervision of Clinicians in Oncology by Psycho-oncologists : Evaluation · NA · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03523039 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire Vaudois
Last refreshed: 14 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03523039.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing